Chemotherapy News and Research

Latest Chemotherapy News and Research

Common culinary spice derivative could treat tendinitis

Common culinary spice derivative could treat tendinitis

GTx reports revenue of $1.6 million for second quarter 2011

GTx reports revenue of $1.6 million for second quarter 2011

Genentech, Array BioPharma sign oncology agreement for ChK-1 development program

Genentech, Array BioPharma sign oncology agreement for ChK-1 development program

Provider groups weigh in with Supreme Court on Calif. Medicaid case; Fla. docs oppose Medicaid revamp

Provider groups weigh in with Supreme Court on Calif. Medicaid case; Fla. docs oppose Medicaid revamp

A.P. Pharma second quarter net loss decreases to $1.9 million

A.P. Pharma second quarter net loss decreases to $1.9 million

Kaan Medikal to distribute Saladax's My5-FU diagnostic test in Turkey

Kaan Medikal to distribute Saladax's My5-FU diagnostic test in Turkey

HPV-related throat cancer cases increase sharply over the past 10 years

HPV-related throat cancer cases increase sharply over the past 10 years

ADVENTRX's second quarter net loss decreases to $4.4 million

ADVENTRX's second quarter net loss decreases to $4.4 million

Bladder cancer patients can benefit from radical cystectomy surgery

Bladder cancer patients can benefit from radical cystectomy surgery

Researchers discover lack of oxygen in the lungs after mold invasion

Researchers discover lack of oxygen in the lungs after mold invasion

Head and neck melanoma patients can benefit from sentinel lymph node biopsy

Head and neck melanoma patients can benefit from sentinel lymph node biopsy

News media registration now open for ASM annual infectious diseases meeting

News media registration now open for ASM annual infectious diseases meeting

PCF funds 10 new Challenge Awards for prostate cancer research

PCF funds 10 new Challenge Awards for prostate cancer research

OncoGenex second quarter revenue increases to $1.9 million

OncoGenex second quarter revenue increases to $1.9 million

ArQule second quarter net loss increases to $10,804,000

ArQule second quarter net loss increases to $10,804,000

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

Innovative delivery systems and methods to treat breast cancer

Innovative delivery systems and methods to treat breast cancer

Vitamin C helps identify more aggressive or treatment resistant tumours

Vitamin C helps identify more aggressive or treatment resistant tumours

Hopkins stem cell research to examine how gene variants cause blood clotting disorders

Hopkins stem cell research to examine how gene variants cause blood clotting disorders

Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia

Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.